These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 31672127)

  • 1. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.
    Chan C; Ryerson CJ; Dunne JV; Wilcox PG
    BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in connective tissue disease-associated interstitial lung disease.
    Duarte AC; Cordeiro A; Fernandes BM; Bernardes M; Martins P; Cordeiro I; Santiago T; Seixas MI; Ribeiro AR; Santos MJ
    Clin Rheumatol; 2019 Jul; 38(7):2001-2009. PubMed ID: 31016581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
    Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
    Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
    Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
    Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias.
    Kondoh Y; Johkoh T; Fukuoka J; Arakawa H; Tanaka T; Watanabe N; Sakamoto K; Kataoka K; Kimura T; Taniguchi H
    Respir Med; 2015 Mar; 109(3):389-96. PubMed ID: 25682542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response.
    Zheng B; Marinescu DC; Hague CJ; Muller NL; Murphy D; Churg A; Wright JL; Al-Arnawoot A; Bilawich AM; Bourgouin P; Cox G; Durand C; Elliot T; Ellis J; Fisher JH; Fladeland D; Grant-Orser A; Goobie GC; Guenther Z; Haider E; Hambly N; Huynh J; Johannson KA; Karjala G; Khalil N; Kolb M; Leipsic J; Lok SD; MacIsaac S; McInnis M; Manganas H; Marcoux V; Mayo J; Morisset J; Scallan C; Sedlic T; Shapera S; Sun K; Tan V; Wong AW; Ryerson CJ
    Rheumatology (Oxford); 2024 Oct; 63(10):2734-2740. PubMed ID: 38336872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
    Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
    PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
    Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
    Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern.
    Meng K; Tian M; Gui X; Xie M; Gao Y; Shi S; Zhao T; Xiao Y; Cai H; Ding J
    Int Immunopharmacol; 2022 Jul; 108():108704. PubMed ID: 35413677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical course and outcome of interstitial pneumonia with autoimmune features.
    Kim HC; Lee JH; Chae EJ; Song JS; Song JW
    Respirology; 2020 Jun; 25(6):636-643. PubMed ID: 31387157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.
    Moua T; Zamora Martinez AC; Baqir M; Vassallo R; Limper AH; Ryu JH
    Respir Res; 2014 Dec; 15(1):154. PubMed ID: 25472884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria.
    Bozzao F; Tomietto P; Baratella E; Kodric M; Cifaldi R; Della Porta R; Prearo I; Pirronello SMG; Confalonieri P; Ruaro B; Fischetti F; Fabris B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109752
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
    Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
    Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.